ChemGenex Pharmaceuticals Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for ChemGenex Pharmaceuticals Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

ChemGenex Pharmaceuticals Limited. The Group's principal activity is operating as an integrated biopharmaceutical development company, focused on discovering and developing oncology drugs. Its product candidates include omacetaxine mepesuccinate (formerly known as Ceflatonin, homoharringtonine or HHT), which is and Quinamed (amonafide dihydrochloride). Operations are carried out in Australia and the United States of America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report